Market Place
Sourcing Support
Another Astrazeneca Emerald Glimmers In Liver Cancer
02 Apr 2026 //
FIERCE PHARMA
AstraZeneca’s Strensiq successor misses ph. 3 rare disease goal
31 Mar 2026 //
FIERCE BIOTECH
Astrazeneca In Vivo Data Shows Potential, Despite Patient Death
28 Mar 2026 //
FIERCE BIOTECH
AstraZeneca`s COPD Hit Revives Class Rocked by Flops
27 Mar 2026 //
FIERCE BIOTECH
AstraZeneca Drug Reduces COPD Flare ups in Late-stage Trials
27 Mar 2026 //
REUTERS
Novartis Pledges $480M for China Expansion Following Lilly and AZ
24 Mar 2026 //
BIOSPACE
The 40th PM Awards – Winners Announced
24 Mar 2026 //
PHARMIWEB
Amani Therapeutics Closes $25 Million Series A to Advance AM-01
23 Mar 2026 //
PHARMIWEB
CDT Advances Out-Licensing With Sarborg Signature Analysis
23 Mar 2026 //
GLOBENEWSWIRE
AZ To Build Cell Therapy Supply Hub, R&D Center In Shanghai
20 Mar 2026 //
PRESS RELEASE
UK Launches AI for Early Oesophageal Cancer Detection
19 Mar 2026 //
BUSSINESSWIRE
AstraZeneca Pharma India receives CDSCO approval for Durvalumab
17 Mar 2026 //
EXPRESSPHARMA
Experts Advocate Mandatory Manufacturer Notification Rules
17 Mar 2026 //
PHARMABIZ
Regulatory Tracker: Az`s Imfinzi Scores EU Label Expansion
16 Mar 2026 //
FIERCE PHARMA
Abivax Denies AstraZeneca Takeover Rumors Reported by Media
13 Mar 2026 //
REUTERS
Arizona Recruits Joshua Jackson, Gritty for Cancer Screening
11 Mar 2026 //
FIERCE PHARMA
AstraZeneca Partners To Promote Cancer Body Check Awareness
10 Mar 2026 //
BUSSINESSWIRE
Astrazeneca Drugs Face FDA Cancer Advisory Panel After 9 Months
09 Mar 2026 //
BIOSPACE
Daiichi Sankyo, AZ`s Enhertu wins US priority review
09 Mar 2026 //
FIERCE PHARMA
FDA to end 9-month adcomm hiatus with review of AZ`s cancer drugs
06 Mar 2026 //
FIERCE PHARMA
CDT Positions For Transformational Growth
04 Mar 2026 //
GLOBENEWSWIRE
FDA Rejection Letters Flag Data Concerns For AZ, GSK Biologics
03 Mar 2026 //
FIERCE PHARMA
AIM ImmunoTech Signs Ampligen Phase 3 Trial Deal
02 Mar 2026 //
GLOBENEWSWIRE
AZ CEO Pay Hits $23.9M Amid Serious `Geopolitical Uncertainty`
24 Feb 2026 //
FIERCE PHARMA
Evinova Secures AI Deals with Astellas, AstraZeneca
24 Feb 2026 //
FIERCE BIOTECH
FDA Approves Venclexta, Acalabrutinib For Untreated CLL Leukemia
23 Feb 2026 //
PRESS RELEASE
Az-Backed Coalition Launches `90S-Inspired Hypertension Campaign
17 Feb 2026 //
FIERCE PHARMA
BREZTRI Shows Positive Phase III Results In Uncontrolled Asthma
13 Feb 2026 //
BUSINESSWIRE
Astrazeneca Grants $3.4M To Enhance US Patient Healthcare Access
11 Feb 2026 //
BUSINESSWIRE
AI Transforms Pharma`s Financials Beyond Drug Discovery
11 Feb 2026 //
BIOSPACE
China indicts AstraZeneca and former exec Leon Wang over data
11 Feb 2026 //
REUTERS
Astrazeneca Relaxed About Relaxin Drug`s Poor Efficacy In Ph. 2
10 Feb 2026 //
FIERCE BIOTECH
Astrazeneca`s Oral GLP-1 Scored Phase 2 Wins, But No Data Yet
10 Feb 2026 //
FIERCE BIOTECH
AstraZeneca Eyes 25+ Blockbusters by 2030
10 Feb 2026 //
FIERCE PHARMA
AstraZeneca Gets CDSCO Nod for Imfinzi in New Indication
10 Feb 2026 //
ECONOMICTIMES
BMS And Evinova Pen Global Development Partnership
09 Feb 2026 //
FIERCE BIOTECH
Pharma Expert Addresses Standardizing CMC Quality Data
06 Feb 2026 //
RAPS
The Biggest Potential Drug Launches Of 2026
06 Feb 2026 //
FIERCE PHARMA
US Government Launches Trumprx Drug Purchasing Portal
06 Feb 2026 //
FIERCE PHARMA
AstraZeneca Wins CDSCO Nod for Durvalumab in Gastric Cancer
06 Feb 2026 //
ECONOMICTIMES
AIM Reports Positive Interim Ph2 Data of Ampligen Combo in Cancer
05 Feb 2026 //
GLOBENEWSWIRE
FDA Priority Review for DATROWAY for Metastatic Breast Cancer
03 Feb 2026 //
BUSINESSWIRE
Astrazeneca Rises 1% Following Historic NYSE Transfer
03 Feb 2026 //
PR NEWSWIRE
FDA Rejects Az`s Subcutaneous Version Of Lupus Drug Saphnelo
03 Feb 2026 //
FIERCE PHARMA
Daiichi Stops Internal Development Of Next-Wave ADC
02 Feb 2026 //
FIERCE BIOTECH
Astrazeneca Begins Trading On The New York Stock Exchange
02 Feb 2026 //
BUSINESSWIRE
AstraZeneca returns to China`s CSPC for $18.5B obesity dea
31 Jan 2026 //
PRESS RELEASE
Astrazeneca Vows $15B China Investment To Boost R&D Capabilities
30 Jan 2026 //
FIERCE BIOTECH
Multiply Labs Partners to Automate Cell Therapy Manufacturing
27 Jan 2026 //
BUSINESSWIRE
AstraZeneca keeps UK Research Site on Pause, But Options Open
27 Jan 2026 //
FIERCE BIOTECH
Daiichi Sankyo Navigates Complexity Of Success
26 Jan 2026 //
FIERCE PHARMA
AstraZeneca keeps UK research site on pause, but options open
26 Jan 2026 //
FIERCE BIOTECH
AstraZeneca to delist from Nasdaq, join NYSE in February
20 Jan 2026 //
REUTERS
ENHERTU + Pertuzumab EU Filing Validated for HER2+ Breast Cancer
19 Jan 2026 //
BUSINESSWIRE
ENHERTU Plus Pertuzumab EU Type II Variation Validated
19 Jan 2026 //
BUSINESSWIRE
AstraZeneca Acquires China Rights to GPC3 Armored CAR-T Therapy
18 Jan 2026 //
PR NEWSWIRE
FDA Proposes Febrile Seizure Warnings on Flu Shot Labels
17 Jan 2026 //
FIERCE PHARMA
AZ`s $80B Revenue Target `Very Much Within Reach,` CFO Says
14 Jan 2026 //
FIERCE PHARMA
Barnardo & Astrazeneca Partner On Young Health Programme For UK
13 Jan 2026 //
PHARMIWEB
DATROWAY Ph 3 TROPION-Lung17 Trial Initiated in NSCLC Cancer
13 Jan 2026 //
BUSINESSWIRE
